Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rimda Wanchoo

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Kidney International Reports|January 11, 2018
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative ReviewKenar D Jhaveri, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
Kidney360|February 23, 2023
Onconephrology 2022: An UpdateMarco Bonilla, Prakash Gudsoorkar, Rimda Wanchoo, et al.
Clinical Kidney Journal|April 2, 2021
Pathology of COVID-19-associated acute kidney injuryPurva Sharma, Jia H Ng, Vanesa Bijol, et al.
American Journal of Hematology|June 1, 2019
Ibrutinib induced acute tubular injury: A case series and review of the literatureSandhya Manohar, Anip Bansal, Rimda Wanchoo, et al.
Kidney360|April 4, 2022
Use of Immune Checkpoint Inhibitors in End Stage Kidney Disease Patients, Single Center Experience and Review of the LiteratureJamie S Hirsch, Rimda Wanchoo, Jia H Ng, et al.
Advances in Chronic Kidney Disease|February 22, 2022
Chronic Kidney Disease in Cancer SurvivorsMeghan Lee, Qiyu Wang, Rimda Wanchoo, et al.
Kidney International Reports|June 15, 2026
AKI After Hepatic HistotripsySalman Bhutta, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
BMC Nephrology|June 23, 2018
Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologistsMary C Mallappallil, Steven Fishbane, Rimda Wanchoo, et al.
Kidney International|January 10, 2014
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancerAzzour D Hazzan, Hitesh H Shah, Susana Hong, et al.
CEN Case Reports|May 17, 2017
Light chain Fanconi syndrome in a patient with acute myeloid leukemia and monoclonal gammopathy of undetermined significanceDaniel W Ross, Rimda Wanchoo, Adriana Guigova, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Kidney International Reports|January 11, 2018
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative ReviewKenar D Jhaveri, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
Kidney360|February 23, 2023
Onconephrology 2022: An UpdateMarco Bonilla, Prakash Gudsoorkar, Rimda Wanchoo, et al.
Clinical Kidney Journal|April 2, 2021
Pathology of COVID-19-associated acute kidney injuryPurva Sharma, Jia H Ng, Vanesa Bijol, et al.
American Journal of Hematology|June 1, 2019
Ibrutinib induced acute tubular injury: A case series and review of the literatureSandhya Manohar, Anip Bansal, Rimda Wanchoo, et al.
Kidney360|April 4, 2022
Use of Immune Checkpoint Inhibitors in End Stage Kidney Disease Patients, Single Center Experience and Review of the LiteratureJamie S Hirsch, Rimda Wanchoo, Jia H Ng, et al.
Advances in Chronic Kidney Disease|February 22, 2022
Chronic Kidney Disease in Cancer SurvivorsMeghan Lee, Qiyu Wang, Rimda Wanchoo, et al.
Kidney International Reports|June 15, 2026
AKI After Hepatic HistotripsySalman Bhutta, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
BMC Nephrology|June 23, 2018
Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologistsMary C Mallappallil, Steven Fishbane, Rimda Wanchoo, et al.
Kidney International|January 10, 2014
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancerAzzour D Hazzan, Hitesh H Shah, Susana Hong, et al.
CEN Case Reports|May 17, 2017
Light chain Fanconi syndrome in a patient with acute myeloid leukemia and monoclonal gammopathy of undetermined significanceDaniel W Ross, Rimda Wanchoo, Adriana Guigova, et al.
Pageof 7